225 related articles for article (PubMed ID: 2191313)
1. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
2. Possible therapeutic application of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Nihon Jinzo Gakkai Shi; 1988 Sep; 30(9):1153-60. PubMed ID: 3216557
[No Abstract] [Full Text] [Related]
3. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
4. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic apheresis in the treatment of drug-resistant primary glomerulonephritis].
Sakai S; Sakai O
Nihon Rinsho; 1992 Jan; 50 Suppl():139-47. PubMed ID: 1578669
[No Abstract] [Full Text] [Related]
6. LDL adsorption improves the response of focal glomerulosclerosis to corticosteroid therapy.
Yokoyama K; Sakai S; Sigematsu T; Takemoto F; Hara S; Yamada A; Kawaguchi Y; Hosoya T
Clin Nephrol; 1998 Jul; 50(1):1-7. PubMed ID: 9710340
[TBL] [Abstract][Full Text] [Related]
7. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of low-density lipoprotein apheresis (LDL-A) on refractory nephrotic syndrome (NS) due to focal glomerulosclerosis (FGS).
Muso E; Mune M; Yorioka N; Nishizawa Y; Hirano T; Hattori M; Sugiyama S; Watanabe T; Kimura K; Yokoyama H; Sato H; Saito T
Clin Nephrol; 2007 Jun; 67(6):341-4. PubMed ID: 17598368
[TBL] [Abstract][Full Text] [Related]
9. [LDL-apheresis for refractory nephrotic syndrome].
Muso E
Nihon Jinzo Gakkai Shi; 2010; 52(7):928-33. PubMed ID: 21077343
[No Abstract] [Full Text] [Related]
10. [A case of focal segmental glomerulosclerosis(FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis].
Takaki A; Nakatsuka A; Satou C; Iwata Y; Ikeda H; Fukushima M
Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):806-12. PubMed ID: 12607970
[TBL] [Abstract][Full Text] [Related]
11. Focal Segmental Glomerular Sclerosis Ameliorated by Long-term Hemodialysis Therapy with Low-density Lipoprotein Apheresis.
Araki H; Ono S; Nishizawa Y; Deji N; Nakazawa J; Morita Y; Kume S; Chin-Kanasaki M; Isshiki K; Araki S; Arimura T; Maegawa H; Uzu T
Intern Med; 2015; 54(17):2213-7. PubMed ID: 26328649
[TBL] [Abstract][Full Text] [Related]
12. An update on LDL apheresis for nephrotic syndrome.
Raina R; Krishnappa V
Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
[TBL] [Abstract][Full Text] [Related]
13. Treatment with a combination of low-density lipoprotein aphaeresis and pravastatin of a patient with drug-resistant nephrotic syndrome due to focal segmental glomerulosclerosis.
Hattori M; Ito K; Kawaguchi H; Tanaka T; Kubota R; Khono M
Pediatr Nephrol; 1993 Apr; 7(2):196-8. PubMed ID: 8476719
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of low-density lipoprotein apheresis for focal and segmental glomerulosclerosis.
Kawasaki Y; Suzuki S; Matsumoto A; Takano K; Suyama K; Hashimoto K; Suzuki J; Suzuki H; Hosoya M
Pediatr Nephrol; 2007 Jun; 22(6):889-92. PubMed ID: 17277952
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
[TBL] [Abstract][Full Text] [Related]
16. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
[TBL] [Abstract][Full Text] [Related]
17. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
[TBL] [Abstract][Full Text] [Related]
18. [Refractory nephrotic syndrome].
Saito T
Nihon Rinsho; 2004 Oct; 62(10):1794-9. PubMed ID: 15500120
[TBL] [Abstract][Full Text] [Related]
19. Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone.
Yokoyama K; Sakai S; Yamaguchi Y; Suzuki Y; Hinoshita F; Hara S; Yamada A; Ogura Y; Kawaguchi Y; Sakai O
Nephron; 1996; 72(2):318-20. PubMed ID: 8684548
[No Abstract] [Full Text] [Related]
20. Apheresis for Kidney Disease.
Furuichi K; Wada T
Contrib Nephrol; 2018; 196():188-193. PubMed ID: 30041226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
